University of Toronto · Strategic Initiative
Precision medicine, accelerated.
PRiME unites world-class investigators across the University of Toronto, its affiliated hospitals, and global partners — turning breakthrough science into diagnostics and therapies that reach patients.
Past events
PRiME Connaught Global Speaker Series
PRiME Seminars in AI and Drug Discovery
May Research Rounds
PRiME Seminars in AI and Drug Discovery
April Research Rounds
PRiME Lunch & Learn Series with DECIEM
PRiME Connaught Global Speaker Series
PRiME Seminars in AI and Drug Discovery
March Research Rounds
PRiME 7th Annual Symposium — Instruments of Change
PRiME January Research Rounds
Swiss–Canadian Innovation Symposium
PRiME Connaught Global Speaker Series
Pitch Competition — Building a Biotech Venture 2025PRiME Connaught Global Speaker SeriesPRiME Seminars in AI and Drug DiscoveryMay Research RoundsPRiME Seminars in AI and Drug DiscoveryApril Research RoundsPRiME Lunch & Learn Series with DECIEMPRiME Connaught Global Speaker SeriesPRiME Seminars in AI and Drug DiscoveryMarch Research RoundsPRiME 7th Annual Symposium — Instruments of ChangePRiME January Research RoundsSwiss–Canadian Innovation SymposiumPRiME Connaught Global Speaker SeriesPitch Competition — Building a Biotech Venture 2025Our purpose
At the convergence of science, medicine & engineering — turning breakthrough discovery into therapies that reach patients.
Vision
Build inclusive, interdisciplinary global research hubs that redefine how next-generation precision medicine is discovered, developed, and delivered.
Mission
Grow interdisciplinary, international research, training and translation pipelines that propel promising therapeutics toward patients.
On LinkedIn
Follow our work
Research areas
Six convergent areas of discovery
Biologics & Protein Engineering
Recombinant antibody-based therapeutics — the fastest-growing class of drugs — built on Toronto's antibody discovery and commercialization expertise.
Nanomedicine & Biomaterials
Nanomaterial agents for gene therapy and targeted delivery that concentrate treatment where it's needed and minimize side effects.
Precision Diagnostics
Molecular and cellular analysis that tailors treatment to disease subtype and stage — the right therapy for the right patient.
Targeted Small Molecule Therapeutics
Molecular therapeutics for cancer and infectious disease, engineered to balance potency with tolerability.
Biology-on-a-Chip
Microfluidic devices that model disease biology and enable ex vivo drug testing on a chip.
High-Throughput Omics & Disease Biology
Genomics and proteomics at scale, paired with deep disease-biology expertise across cancer, metabolic disease, and inflammation.
Disease priorities
Three frontiers where precision matters most
Precision Aging
Decoding the biology of aging to keep people healthier for longer.
Precision Oncology
Matching cancer treatment to the molecular signature of each tumour.
Precision Women's Health
Closing long-standing gaps in research and care for women's health.
In the spotlight
Moments from the PRiME community
Programs
From the bench to translation
What's on
Seminars, symposia & more
Latest news
From the PRiME community
A global community
In collaboration with leading institutions worldwide
With affiliated hospitals
Leadership
Directed by world-leading scientists
Molly Shoichet
Scientific Director
Carolyn Cummins
Associate Scientific Director
Akshita Vincent
Director, Strategy & Partnerships
Meenakshi Venkatesan
Program Officer
Natalie Gonsalves
Marketing & Events Officer
Join a global community accelerating precision medicine.
PRiME members gain access to funding, collaborations, training, and a network spanning the University of Toronto and the world.